Prisoners should not be left behind in HCV research and policies.
Journal
Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624
Informations de publication
Date de publication:
24 05 2020
24 05 2020
Historique:
received:
30
04
2020
accepted:
13
05
2020
entrez:
26
5
2020
pubmed:
26
5
2020
medline:
13
7
2021
Statut:
epublish
Résumé
With a worldwide prevalence of 15.4%, hepatitis C virus (HCV) has been estimated to be the most prevalent major infectious disease in prisons. The exceptionally high prevalence of HCV in prisons is attributable to common risk behaviors including sharing contaminated tattooing equipment and drug paraphernalia, as well as lack of HCV control interventions including needle and syringe programs. Despite the importance of attention to prisoners as a highly at-risk population to acquire and transmit HCV, the number of HCV research and policy documents ignoring prisoners is increasing. Highlighting this issue, the present manuscript discusses how excluding prisoners from HCV-related research and policies will jeopardize the global HCV elimination goals set forth by the global community.
Identifiants
pubmed: 32448290
doi: 10.1186/s12954-020-00379-y
pii: 10.1186/s12954-020-00379-y
pmc: PMC7245876
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
33Références
Lancet. 2019 Mar 30;393(10178):1319-1329
pubmed: 30704789
Lancet. 2019 Jul 27;394(10195):301-302
pubmed: 31354141
Lancet. 2016 Sep 10;388(10049):1115-1126
pubmed: 27427456
Epidemiol Rev. 2018 Jun 1;40(1):58-69
pubmed: 29860343
J Viral Hepat. 2019 Dec;26(12):1388-1403
pubmed: 31392812
Lancet. 2016 Sep 10;388(10049):1089-1102
pubmed: 27427453